Content area
Abstract
[...] the potential heterotypic cross-protection that is offered by this monovalent G1P[8] rotavirus vaccine against strains with neither G1 nor P[8] specificity has stimulated international interest and speculation.
You might have access to more details...
Try and log in through your library or institution to see if they have access.
[...] the potential heterotypic cross-protection that is offered by this monovalent G1P[8] rotavirus vaccine against strains with neither G1 nor P[8] specificity has stimulated international interest and speculation.